Table 1.
Ir Complex |
HeLa IC50 | A549 IC50 | Luminescence | Special Features | |||
---|---|---|---|---|---|---|---|
Dark | Light (Irradiation nm) | Dark | Light (Irradiation nm) | λEm (nm) | λEx (nm) | ||
IR2 | 2.1 ± 0.2 | 1.7 ± 0.1 | 630–690 | 405 | Could cause concentration-dependent cell cycle arrest, pro-death autophagy, and caspase-dependent apoptosis in A549 cells. | ||
IR6 | 11.3 ± 0.1 | 15.6 ± 1.2 | Could induce cancer cell death in a variety of ways and had a good antimetastatic ability to cancer cells. | ||||
IR13 | 3.6 ± 0.8 | 2.6 ± 0.3 | 500–600 | 488 | Fluorescence could be used for cellular imaging under both acidic and neutral conditions. | ||
IR15 | >100 | 0.21 ± 0.01 (425) | >100 | 0.31 ± 0.02 (425) | 670 | 405 | Had enhanced emission in lysosomes and could inhibit several key cancerous events, including cell migration, invasion, colony formation, and in vivo angiogenesis. |
IR16 | 4.34 ± 0.01 | 591 | 488 | Potential anticancer agents with dual functions, including metastasis-inhibition and lysosomal damage. | |||
IR17 | 62.3 ± 2.6 | 1.1 ± 0.3 (465) | 580–630 | 563 | Photo-selective and cancer-selective in cell and spheroids. | ||
IR21 | 11.5 ± 0.2 | 0.044 ± 0.006 (420) | 557 | 381 | The first iridium complexes to induce cancer cell death by inhibition of translation targeting the endoplasmic reticulum. | ||
IR22 | 49.9 ± 0.1 * | 0.75 ± 0.01 (visible) |
608 | 405 | Nanomolar photocytotoxicity and visible PI > 280. | ||
IR23 | 506 | 366 | The first example of an artificial TRAIL mimic that induced apoptosis-like cell death. | ||||
IR24 | 460–510 | 400 | Folate targeted multi-action micelle, activated by GHS and irradiation at 400nm. |
* IC50 values in SK-MEL-28 cells, as neither HeLa nor A549 have been published.